Markus Moehler is Head of GI Oncology, at Mainz University Clinic. After studies at Heidelberg, Germany and Yeshiva University, New York, and MD supervised by Nobel Prize laureate Prof. Drs. H. zur Hausen, he was 2-years-postDoc at the German Cancer Research Center, Heidelberg, Germany.

 

He received his Degree of Internal Medicine (2003) and his ESMO Certificate (2003). In February 2005 he achieved his PhD and became Junior Professor and Gastroenterologist, as well as Senior Consultant for Gastroenterology and Gastrointestinal Oncology.

 

Apart from German associations (Arbeitsgemeinschaft Internistische Onkologie (AIO), DGVS, DGHO), he has been an active member and past chair of the EORTC GI group, active member of American Society of Clinical Oncology (ASCO), European Society of Medical Oncology (ESMO) for more than 20 years.

 

Over the past 20 years, he has been principal investigator (PI) on numerous national and international innovative phase I-III clinical studies. Currently he is PI on many international clinical studies, particularly on new targeted and immune therapeutic agents

Prof. Markus Moehler has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

AIO, Amgen, Bayer, Beigene, BMS, Daiichi, EORTC, Falk foundation, Lilly, MD, MSD, Novartis, Sanofi, Servier, Taiho